Replies to post #334822 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

They could ask for another extension. Since it is an ADF and the FDA supposedly wants ADFs , they may let them slide thru.

[The ELTP King]

We were all looking forward to your thoughts on the following but we got your post in the quote below instead.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156097615

We NEED to know your DOCTORATE degree level thinking on why BOTH Adderall products were JUST switched to Elite's name.

In regards to annual GDUFA fees, a medium-sized pharma has between 6-19 approved ANDA. I count 13 unique active ANDA listed in the FDA Orange Book for Elite Labs, and there are also 3 discontinued ANDA. The ANDA's cover the 11 drugs listed on the Elite website products page (link below). The reason there are 13 ANDA and only 11 drug products is because Elite has 4 active ANDA for phentermine but lists only 2 current phentermine products. (Interestingly, the 3 ANDA listed as discontinued are also for phentermine.)

[WeeZuhl]

In regards to annual GDUFA fees, a medium-sized pharma has between 6-19 approved ANDA. I count 13 unique active ANDA listed in the FDA Orange Book for Elite Labs

It's kind of like gin. You have to put down cards to pick up cards. With 13 listed ANDA, Nasrat has room in his hand for 6 more cards, to make 19. That's when things get interesting. And that's why I want to see more ANDA applications soon and soon again.